AAAAAA

   
Results: 1-9 |
Results: 9
USE OF MYCOPHENOLATE MOFETIL IN PATIENTS WITH CHRONIC CYCLOSPORINE NEPHROTOXICITY
Authors: WOMBOLT DG MCCUNE TR STEWART M
Citation: Dg. Wombolt et al., USE OF MYCOPHENOLATE MOFETIL IN PATIENTS WITH CHRONIC CYCLOSPORINE NEPHROTOXICITY, Transplantation proceedings, 30(4), 1998, pp. 1194-1194
LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
Authors: CHRYSANT SG WOMBOLT DG FELICIANO N ZHENG HJ
Citation: Sg. Chrysant et al., LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Current therapeutic research, 59(11), 1998, pp. 762-772
POLY[ALLYLAMINE] HYDROCHLORIDE (RENAGEL(R)) [RG] WITH AND WITHOUT SUPPLEMENTAL CALCIUM [C] FOR HYPERPHOSPHATEMIA [HP] IN ESRD
Authors: CHERTOW GM BURKE SK GOLDBERG D BLEYER AJ GARRETT BN DOMOTO DT WILKES BM WOMBOLT DG SLATOPOLOSKY E
Citation: Gm. Chertow et al., POLY[ALLYLAMINE] HYDROCHLORIDE (RENAGEL(R)) [RG] WITH AND WITHOUT SUPPLEMENTAL CALCIUM [C] FOR HYPERPHOSPHATEMIA [HP] IN ESRD, Journal of the American Society of Nephrology, 8, 1997, pp. 2559-2559
HLA CREG VERSUS DR MISMATCHES FOR LONG-TERM SURVIVAL OF CADAVERIC RENAL-TRANSPLANTS IN ANTIBODY-POSITIVE PATIENTS
Authors: ARNOLD AN WOMBOLT DG HIGGINS MR MCCUNE TR YEH BPY WHELAN TV CHIDESTER PD RESTAINO I SOLHAUG M BUXTON V MCLIN J STEWART M HURWITZ RL
Citation: An. Arnold et al., HLA CREG VERSUS DR MISMATCHES FOR LONG-TERM SURVIVAL OF CADAVERIC RENAL-TRANSPLANTS IN ANTIBODY-POSITIVE PATIENTS, Human immunology, 55, 1997, pp. 127-127
SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE - 2-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS - A REPORT OFTHE NEORAL STUDY-GROUP
Authors: PESCOVITZ MD BARONE G CHOC MG HRICIK DE HWANG DS JIN JHJ KLEIN JB MARSH CL MIN DI POLLAK R PRUETT TL STINSON JB THOMPSON JS VAZQUES E WAID T WOMBOLT DG WONG RL
Citation: Md. Pescovitz et al., SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE - 2-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS - A REPORT OFTHE NEORAL STUDY-GROUP, Transplantation, 63(5), 1997, pp. 778-780
SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G BUNKE CM CHOC MG HRICIK DE JIN JHJ KLEIN JB MARSH CL MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation proceedings, 28(4), 1996, pp. 2183-2186
THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G CHANG CT CHOC MG KLEIN JB MARSH CL MELIGENI JA MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation, 61(6), 1996, pp. 875-880
THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G BUNKE CM CHOC MG HRICIK DE JIN JHJ KLEIN JB MARSH CL MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation, 61(6), 1996, pp. 968-970
AMLODIPINE VERSUS ATENOLOL IN ESSENTIAL-HYPERTENSION
Authors: FRISHMAN WH BROBYN R BROWN RD JOHNSON BF REEVES RL WOMBOLT DG
Citation: Wh. Frishman et al., AMLODIPINE VERSUS ATENOLOL IN ESSENTIAL-HYPERTENSION, The American journal of cardiology, 73(3), 1994, pp. 10000050-10000054
Risultati: 1-9 |